Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Tuesday, November 24, 2009, 8:48pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
Enter symbol(s):
Market:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
|
Alphabetical List
Albany Molecular Research Inc. (AMRI)
At 5:00AM SGT:
8.35 USD
0.00 (0.00%)
MORE ON AMRI
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Albany Molecular Research, Inc.
(NasdaqNM:AMRI) Delayed quote data
Last Trade:
8.35 USD
Trade Time:
5:00AM SGT
Change:
0.00 (0.00%)
Prev Close:
8.35
Open:
N/A
Bid:
7.80
x 100
Ask:
8.43
x 200
1y Target Est:
8.00
Day's Range:
N/A - N/A
52wk Range:
7.31 - 12.56
Volume:
0
Avg Vol
(3m)
:
100,960
Market Cap:
264.22M
P/E
(ttm)
:
46.13
EPS
(ttm)
:
0.18
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Use Y! Toolbar to track stocks
Add AMRI to Portfolio
Download Data
HEADLINES
ALBANY MOLECULAR RESEARCH INC Financials
EDGAR Online Financials
(Fri, Nov 13)
AMRIâs quarterly earnings, revenue down
at bizjournals.com
(Mon, Nov 9)
ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
EDGAR Online
(Mon, Nov 9)
Q3 2009 Albany Molecular Research Earnings Release - Before Market Open
CCBN
(Mon, Nov 9)
AMRI Announces Third Quarter 2009 Results
Business Wire
(Mon, Nov 9)
AMRI receives $750K milestone payment
at bizjournals.com
(Tue, Nov 3)
Third Compound from AMRI Bristol-Myers Squibb Collaboration Selected for Preclinical Development
Business Wire
(Mon, Nov 2)
AMRI to Present at the Oppenheimer 20th Annual Healthcare Conference
Business Wire
(Fri, Oct 30)
AMRI to Announce Third Quarter Results
Business Wire
(Mon, Oct 26)
Daines: Treat flu-like symptoms as H1N1
at bizjournals.com
(Fri, Oct 23)
More Headlines for AMRI...
ANALYST
EPS Est (next year)
(Dec-09)
:
0.03
EPS Est (in 2 years)
(Dec-10)
:
0.11
Avg Rec (current)*:
3.0
PEG Ratio:
27.13
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
Albany Molecular Research, Inc. provides contract services to various pharmaceutical and biotechnology companies primarily in the United States and Europe.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
Latest News
Singapore Indices